Tocopherol and tocotrienol aerosols
AssigneeChildren's Hospital & Research Center at Oakland
InventorsBruce Ames, Qing Jiang
Life of this patent
Estimating the term…
Abstract
Anti-inflammatory compositions include medicaments comprising predetermined amounts of a phytyl substituted chromanol and a prostaglandin E2 inhibitor, wherein: said medicament is in unit dosage form suitable for pharmaceutical administration; said phytyl substituted chromanol is a gamma-tocopherol, delta-tocopherol, gamma-tocotrienol or delta-tocotrienol; said PGE2 inhibitor is a non-steroidal anti-inflammatory drug or an omega-3 fatty acid, such as docosahexaenoic acid and eicosapentaenoic acid.
Claims21
1-13. (canceled)
A method of inhibiting cancer cell proliferation, the method comprising the step of treating cells with a medicament comprising a synergistic combination of gamma-tocopherol and at least one additional phytyl substituted-chromanol selected from the group consisting of delta-tocopherol, gamma-tocotrienol, and delta-tocotrienol,
- wherein the medicament comprises less than 5% alpha-tocopherol, and the cancer is selected from prostate cancer and lung cancer, whereby cancer cell proliferation is inhibited.
A medicament in an inhalant dosage form, the medicament comprising a combination of effective and synergistic amounts of gamma-tocopherol and at least one additional phytyl substituted chromanol selected from the group consisting of delta-tocopherol, gamma-tocotrienol, and delta-tocotrienol;
- wherein the medicament comprises less than 5% alpha-tocopherol.
Dependencies are inferred from the claim text.